88 results
424B5
ABBV
Abbvie Inc
26 Feb 24
Prospectus supplement for primary offering
6:12am
to physicians and other licensed healthcare providers. In the United States, AbbVie distributes pharmaceutical products principally through independent
424B5
ABBV
Abbvie Inc
21 Feb 24
Prospectus supplement for primary offering
8:39am
products and devices) are also sold directly to physicians and other licensed healthcare providers. In the United States, AbbVie distributes
8-K
EX-99.2
qfb0ln1zvkxx1nfc
6 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
5:28pm
8-K
EX-99.2
8bh a2lh6ptccaw
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
8:47am
PX14A6G
qoyrsnqq8vdjy
4 May 23
Letter to shareholders
8:08am
PX14A6G
14u6 fo4xx
11 Apr 22
Letter to shareholders
4:35pm